Rassael H, Thompson L D, Heffess C S
Department of Endocrine and Otorhinolaryngic Pathology, Armed Forces Institute of Pathology, Washington DC 20306-6000, USA.
Eur Arch Otorhinolaryngol. 1998;255(9):462-7. doi: 10.1007/s004050050100.
Microscopic papillary carcinoma of the thyroid gland (MPC) measuring < or = 1.0 cm in diameter has a generally benign outcome, but is often overtreated with additional surgery. Ninety cases of MPC and 77 cases of nonmicroscopic papillary carcinoma of the thyroid gland (non-MPC) from 1970 to 1980 were retrieved from the Endocrine Registry of the Armed Forces Institute of Pathology (AFIP), Washington, D.C. Histologic features and patient follow-up were analyzed. Twenty-one patients with MPC had multifocal disease within the affected thyroid lobe, while a further 15 had either bilateral or intraglandular spread. Four of 10 patients who had additional surgery were found to have additional foci of tumor. Fourteen patients with lymph node metastases at initial surgery had no subsequent nodal metastases. All patients were either alive without disease or had died of unrelated causes after an average follow-up period of 17.3 years. Of the 77 non-MPC patients, 13 developed lymph node metastases or local recurrences, and one died of metastatic disease. Sixty-four of these patients were alive without evidence of disease after an average follow-up of 22 years. Present findings show that while MPC may present with perithyroidal lymph node metastases (15.56%), patients do not develop clinical tumors in the remaining thyroid tissue. Our experience indicates that close clinical follow-up without additional surgery is the preferable management for patients with MPC.
直径小于或等于1.0厘米的甲状腺微小乳头状癌(MPC)通常预后良好,但常常因接受额外手术而过度治疗。从华盛顿特区武装部队病理研究所(AFIP)的内分泌登记处检索出1970年至1980年期间的90例MPC和77例非微小甲状腺乳头状癌(非MPC)病例。对其组织学特征和患者随访情况进行了分析。21例MPC患者在受影响的甲状腺叶内有多灶性病变,另有15例有双侧或腺内扩散。在接受额外手术的10例患者中,有4例被发现有额外的肿瘤病灶。14例在初次手术时有淋巴结转移的患者随后无淋巴结转移。所有患者在平均随访17.3年后要么无病存活,要么死于无关原因。在77例非MPC患者中,13例发生了淋巴结转移或局部复发,1例死于转移性疾病。这些患者中有64例在平均随访22年后无病存活。目前的研究结果表明,虽然MPC可能伴有甲状腺周围淋巴结转移(15.56%),但患者在其余甲状腺组织中不会出现临床肿瘤。我们的经验表明,对于MPC患者,密切的临床随访而不进行额外手术是更可取的治疗方法。